Clinical Trials Browser

Interventional × Prostatic Neoplasms × ciforadenant × Clear all

NCT02655822 2021-08-30

Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers

Phase 1 Completed

Carcinoma, Renal Cell, Kidney Neoplasms, Prostatic Neoplasms